Drug Development Seminar Series (9/28): Amgen

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

Drug Development Seminar Series (9/28): Amgen

Learn how biotech groups develop novel therapeutics - ranging from CAR-T cell therapies to mRNA COVID-19 vaccines!

In our second installment of the series, Dr. Cen Xu of Amgen will be discussing the development of Aimovig, a monoclonal antibody for the prevention of chronic migraines.

Sign in to Google to save your progress. Learn more

* Indicates required question

Email *

Your email

Name *

Your answer

What department are you in? *

Your answer

How did you hear about this event?

Your answer

Send me a copy of my responses.

Submit

Clear form

Never submit passwords through Google Forms.

reCAPTCHA

This form was created inside of UVa. Report Abuse